Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

392 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

Analyzing Retinal Microanatomy in ROP

NCT02887157

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Infant, Newborn, Diseases, +8 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Washington University St Louis, Missouri, United States
  • Duke University Eye Center Durham, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

NCT03481634

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site La Jolla, California, United States
  • Novartis Investigative Site Mountain View, California, United States
View all 116 locations
View Trial Details
Completed

A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease

NCT03161912

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +16 more
Locations
  • Many Locations Multiple Locations, China
  • Many Locations Multiple Locations, Egypt
  • Many Locations Multiple Locations, France
  • Many Locations Multiple Locations, Germany
View Trial Details
Completed

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

NCT03917472

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Beverly Hills, California, United States
View all 92 locations
View Trial Details
Completed

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion

NCT03108352

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +9 more
Locations
  • The General Hospital of the People's Liberation Army Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, China
  • Beijing Tongren Hospital, Capital Medical University Beijing, China
  • Peking Union Medical College Hospital Beijing, China
View all 31 locations
View Trial Details

Related conditions